Simultaneous determination of pregnenolone and 17α-hydroxypregnenolone by semi-micro high-performance liquid chromatography with an immobilized cholesterol oxidase as a pre-column reactor: application to bovine adrenal fasciculata cells.
Susumu Yamato, Saori Nakagawa, Natsumi Yamazaki, Takao Aketo, Eiichi Tachikawa
Index: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 878(32) , 3358-62, (2010)
Full Text: HTML
Abstract
A method for the simultaneous determination of pregnenolone and 17α-hydroxypregnenolone by high-performance liquid chromatography with an immobilized cholesterol oxidation enzyme reactor was developed. Pregnenolone and 17α-hydroxypregnenolone were converted to progesterone and 17α-hydroxyprogesterone, respectively, by the immobilized enzyme packed into the reactor column, and could thus be monitored by UV absorption at 240 nm. The calibration curves for pregnenolone and 17α-hydroxypregnenolone were linear in the range of 0.4-10 and 0.3-10 μg/ml with a correlation coefficient of 0.9993 and 0.9998, respectively. The detection limit at a signal-to-noise ratio of 3 was 0.12 and 0.08 μg/ml for pregnenolone and 17α-hydroxypregnenolone, respectively. The conversion rate of pregnenolone to progesterone and 17α-hydroxypregnenolone to 17α-hydroxyprogesterone was 90.6% and 99.3%, respectively. Intra-day and inter-day precision (in terms of percentage coefficient of variation) were less than 9.3%, with accuracy greater than 94.8%. This method was successfully applied to the simultaneous determination of pregnenolone and 17α-hydroxypregnenolone secreted into the culture medium of bovine adrenal fasciculata cells and of both analytes produced within the cells.Copyright © 2010 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR.
2013-06-07
[J. Biol. Chem. 288(23) , 17008-18, (2013)]
2010-01-01
[Horm. Res. Paediatr. 74(5) , 358-64, (2010)]
2011-01-01
[Endocr. J. 58(7) , 527-34, (2011)]
2008-09-10
[J. Pharm. Biomed. Anal. 48(1) , 177-82, (2008)]
[The alternative androgen synthesis pathway in humans].
2013-01-01
[Klin. Padiatr. 225(1) , 3-7, (2013)]